/   Home   /   Newsroom   /   Research News

Integrative Analysis Identifies BTN3A2 as a Novel Schizophrenia Risk Gene

Jun 28, 2019     Email"> PrintText Size

Schizophrenia is a complex, highly heritable and heterogeneous disease with estimated heritability ranging up to 80%. It affects approximately 0.5-1% of the world population.  

During the past decade, numerous schizophrenia-associated variants and loci in world-wide populations have been identified, but most of the risk single-nucleotide polymorphisms (SNPs) or variants identified by GWASs were located in intergenic, intronic or other non-coding regions.  

To identify the causal genes at the reported risk loci and to elucidate how these risk genes influence the pathogenesis of schizophrenia remains a daunting task. Previous studies showed that most complex disease-associated variants confer risk for the illnesses by acting as eQTL to influence gene expression in cis or in trans.  

By integrating a large-scale schizophrenia GWAS data and brain prefrontal cortex expression quantitative trait loci (eQTL) data, a team of scientists from the Kunming Institute of Zoology (KIZ) of the Chinese Academy of Sciences identified BTN3A2 as a potential schizophrenia risk gene in the Major Histocompatibility Complex (MHC) region.  

Result from linkage disequilibrium showed that BTN3A2 was independent from the schizophrenia risk gene C4A. Furthermore, they found that BTN3A2 expression in human brain was highest postnatally and this gene was highly expressed in schizophrenia subjects compared with healthy controls.  

Evolutionary analysis found that BTN3A2 was a primate specific gene. To study the function of BTN3A2 during synaptic transmission, they used cultured rat hippocampal slice as the study system and expressed BTN3A2 exogenously in CA1 neurons through biolistic transfection.   

The results showed that overexpression of BTN3A2 decreased both AMPAR and NMDAR-mediated excitatory synaptic transmission compared with the control neurons, while no effect was seen on the ratio of AMPA and NMDA EPSCs. 

Moreover, overexpression of BTN3A2 decreased the presynaptic release probability, most likely through its interaction with the presynaptic adhesion molecule neurexins. These results from integrative analyses and functional characterization suggested that BTN3A2 may confer risk of schizophrenia by altering excitatory synaptic function.  

The study, published in EBioMedicine, was supported by the Strategic Priority Research Program (B) of the Chinese Academy of Sciences, the National Natural Science Foundation of China, and the Bureau of Frontier Sciences and Education, Chinese Academy of Sciences. 

(Editor: LI Yuan)

Contact

Related Articles

schizophrenia;psychology;disorder

Individuals with Schizotypy Opt for Immediate but Smaller Rewards in the Future

Jan 14, 2019

Dr. Raymond Chan from the Neuropsychology and Applied Cognitive Neuroscience of Institute of Psychology, together with Prof. DING Jinhong from the Department of Psychology of Capital Normal University, have conducted a study to examine the delay disco...

schizophrenia;autism spectrum disorder;ASD;MIR-137

'Master Key' Gene Has Links to both ASD and Schizophrenia

Nov 06, 2018

Recent studies of complex brain disorders such as schizophrenia and autism spectrum disorder (ASD) have identified a few "master keys," risk genes that sit at the center of a network of genes important for brain function. Researchers at Emory and the C...

schizophrenia;special issue;schizotypy research

Scientists Publish a Special Issue "Crossing Borders in Schizotypy Research"

Oct 30, 2018

Schizophrenia Bulletin has published a special issue on schizotypy titled "Crossing Borders in Schizotypy Research" based on the materials of the 2017 International Consortium on Schizotypy Research Conference in Beijing. One of the highlights of this ...

Contact Us

Copyright © 2002 - Chinese Academy of Sciences